Corporate Governance

Founded in 1995, JOINN Laboratories (stock codes: 603127.SH / 6127.HK) is a leading global Contract Research Organization (CRO) with operations in major cities across China - including Beijing, Suzhou, and Guangzhou, as well as in the United States, with facilities in San Francisco and Boston. JOINN is dedicated to accelerating the research and development of innovative therapies by delivering high-quality, globally aligned services. Our qualifications include CNAS/ILAC accreditation, multi-country GLP compliance (China, the United States, the OECD, Japan, and South Korea), and AAALAC accreditation, ensuring the highest international standards of quality and reliability.

Our comprehensive service portfolio spans the entire drug development lifecycle, covering drug discovery, pharmaceutical quality research and testing, non-clinical safety assessment, clinical trials, and post-marketing pharmacovigilance. In addition, JOINN offers specialized expertise in experimental animal disease models, veterinary drug development, agrochemical evaluation, and medical device assessment. Guided by our mission ─ "Safety Assessment and Life Cycle Monitoring for Your Pharmaceutical Innovations", JOINN combines deep scientific expertise with operational excellence to help global partners bring life-changing therapies to patients safely, efficiently, and with confidence.